nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—locus ceruleus—Alzheimer's disease	0.0255	0.141	CbGeAlD
Naratriptan—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0164	0.0908	CbGeAlD
Naratriptan—HTR1D—telencephalic ventricle—Alzheimer's disease	0.0159	0.0879	CbGeAlD
Naratriptan—HTR1A—telencephalic ventricle—Alzheimer's disease	0.0133	0.0733	CbGeAlD
Naratriptan—HTR1F—forebrain—Alzheimer's disease	0.0105	0.0579	CbGeAlD
Naratriptan—HTR1F—telencephalon—Alzheimer's disease	0.00962	0.0532	CbGeAlD
Naratriptan—HTR1B—blood vessel—Alzheimer's disease	0.00813	0.0449	CbGeAlD
Naratriptan—HTR1D—blood vessel—Alzheimer's disease	0.00787	0.0435	CbGeAlD
Naratriptan—HTR1F—nervous system—Alzheimer's disease	0.00568	0.0314	CbGeAlD
Naratriptan—HTR1F—central nervous system—Alzheimer's disease	0.00547	0.0302	CbGeAlD
Naratriptan—HTR1F—brain—Alzheimer's disease	0.00434	0.024	CbGeAlD
Naratriptan—HTR1B—forebrain—Alzheimer's disease	0.00429	0.0237	CbGeAlD
Naratriptan—HTR1D—forebrain—Alzheimer's disease	0.00415	0.023	CbGeAlD
Naratriptan—HTR1B—telencephalon—Alzheimer's disease	0.00394	0.0218	CbGeAlD
Naratriptan—HTR1D—telencephalon—Alzheimer's disease	0.00382	0.0211	CbGeAlD
Naratriptan—MAOA—embryo—Alzheimer's disease	0.00357	0.0198	CbGeAlD
Naratriptan—HTR1A—forebrain—Alzheimer's disease	0.00346	0.0191	CbGeAlD
Naratriptan—HTR1A—telencephalon—Alzheimer's disease	0.00318	0.0176	CbGeAlD
Naratriptan—MAOA—forebrain—Alzheimer's disease	0.00316	0.0175	CbGeAlD
Naratriptan—MAOA—telencephalon—Alzheimer's disease	0.00291	0.0161	CbGeAlD
Naratriptan—HTR1B—nervous system—Alzheimer's disease	0.00233	0.0129	CbGeAlD
Naratriptan—HTR1D—nervous system—Alzheimer's disease	0.00225	0.0125	CbGeAlD
Naratriptan—HTR1B—central nervous system—Alzheimer's disease	0.00224	0.0124	CbGeAlD
Naratriptan—HTR1D—central nervous system—Alzheimer's disease	0.00217	0.012	CbGeAlD
Naratriptan—HTR1A—nervous system—Alzheimer's disease	0.00188	0.0104	CbGeAlD
Naratriptan—HTR1A—central nervous system—Alzheimer's disease	0.00181	0.01	CbGeAlD
Naratriptan—HTR1B—brain—Alzheimer's disease	0.00178	0.00984	CbGeAlD
Naratriptan—HTR1A—cerebellum—Alzheimer's disease	0.00177	0.00978	CbGeAlD
Naratriptan—HTR1D—brain—Alzheimer's disease	0.00172	0.00953	CbGeAlD
Naratriptan—MAOA—nervous system—Alzheimer's disease	0.00172	0.00949	CbGeAlD
Naratriptan—Eletriptan—PTGS1—Alzheimer's disease	0.00168	0.391	CrCbGaD
Naratriptan—MAOA—central nervous system—Alzheimer's disease	0.00165	0.00914	CbGeAlD
Naratriptan—MAOA—cerebellum—Alzheimer's disease	0.00161	0.00893	CbGeAlD
Naratriptan—Almotriptan—CYP2D6—Alzheimer's disease	0.00147	0.342	CrCbGaD
Naratriptan—HTR1A—brain—Alzheimer's disease	0.00144	0.00794	CbGeAlD
Naratriptan—MAOA—brain—Alzheimer's disease	0.00131	0.00725	CbGeAlD
Naratriptan—Eletriptan—CYP2D6—Alzheimer's disease	0.00115	0.266	CrCbGaD
Naratriptan—Pollakiuria—Donepezil—Alzheimer's disease	0.00106	0.00183	CcSEcCtD
Naratriptan—Arrhythmia—Galantamine—Alzheimer's disease	0.00106	0.00183	CcSEcCtD
Naratriptan—Gastritis—Rivastigmine—Alzheimer's disease	0.00104	0.0018	CcSEcCtD
Naratriptan—Asthma—Memantine—Alzheimer's disease	0.00104	0.0018	CcSEcCtD
Naratriptan—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00103	0.00179	CcSEcCtD
Naratriptan—Pneumonia—Donepezil—Alzheimer's disease	0.00103	0.00178	CcSEcCtD
Naratriptan—Depression—Donepezil—Alzheimer's disease	0.00102	0.00176	CcSEcCtD
Naratriptan—Angina pectoris—Memantine—Alzheimer's disease	0.00101	0.00175	CcSEcCtD
Naratriptan—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00101	0.00174	CcSEcCtD
Naratriptan—Myocardial infarction—Donepezil—Alzheimer's disease	0.001	0.00173	CcSEcCtD
Naratriptan—Bronchitis—Memantine—Alzheimer's disease	0.001	0.00173	CcSEcCtD
Naratriptan—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000991	0.00171	CcSEcCtD
Naratriptan—Muscle spasms—Galantamine—Alzheimer's disease	0.00099	0.00171	CcSEcCtD
Naratriptan—Sweating—Donepezil—Alzheimer's disease	0.000979	0.00169	CcSEcCtD
Naratriptan—Bronchitis—Rivastigmine—Alzheimer's disease	0.000979	0.00169	CcSEcCtD
Naratriptan—Vision blurred—Galantamine—Alzheimer's disease	0.000971	0.00168	CcSEcCtD
Naratriptan—Tremor—Galantamine—Alzheimer's disease	0.000965	0.00167	CcSEcCtD
Naratriptan—Pollakiuria—Memantine—Alzheimer's disease	0.000961	0.00166	CcSEcCtD
Naratriptan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000956	0.00165	CcSEcCtD
Naratriptan—Anaemia—Galantamine—Alzheimer's disease	0.000952	0.00165	CcSEcCtD
Naratriptan—Agitation—Galantamine—Alzheimer's disease	0.000947	0.00164	CcSEcCtD
Naratriptan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00094	0.00163	CcSEcCtD
Naratriptan—Hyperglycaemia—Memantine—Alzheimer's disease	0.000939	0.00162	CcSEcCtD
Naratriptan—Bradycardia—Donepezil—Alzheimer's disease	0.000934	0.00161	CcSEcCtD
Naratriptan—Pneumonia—Memantine—Alzheimer's disease	0.000933	0.00161	CcSEcCtD
Naratriptan—Malaise—Galantamine—Alzheimer's disease	0.000929	0.00161	CcSEcCtD
Naratriptan—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000929	0.00161	CcSEcCtD
Naratriptan—Vertigo—Galantamine—Alzheimer's disease	0.000926	0.0016	CcSEcCtD
Naratriptan—Depression—Memantine—Alzheimer's disease	0.000925	0.0016	CcSEcCtD
Naratriptan—Syncope—Galantamine—Alzheimer's disease	0.000924	0.0016	CcSEcCtD
Naratriptan—Haemoglobin—Donepezil—Alzheimer's disease	0.000922	0.00159	CcSEcCtD
Naratriptan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000918	0.00159	CcSEcCtD
Naratriptan—Haemorrhage—Donepezil—Alzheimer's disease	0.000917	0.00159	CcSEcCtD
Naratriptan—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000914	0.00158	CcSEcCtD
Naratriptan—Pneumonia—Rivastigmine—Alzheimer's disease	0.000913	0.00158	CcSEcCtD
Naratriptan—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000913	0.00158	CcSEcCtD
Naratriptan—Hallucination—Donepezil—Alzheimer's disease	0.000913	0.00158	CcSEcCtD
Naratriptan—Palpitations—Galantamine—Alzheimer's disease	0.00091	0.00157	CcSEcCtD
Naratriptan—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000909	0.00157	CcSEcCtD
Naratriptan—Myocardial infarction—Memantine—Alzheimer's disease	0.000909	0.00157	CcSEcCtD
Naratriptan—Drowsiness—Rivastigmine—Alzheimer's disease	0.000908	0.00157	CcSEcCtD
Naratriptan—Loss of consciousness—Galantamine—Alzheimer's disease	0.000905	0.00157	CcSEcCtD
Naratriptan—Depression—Rivastigmine—Alzheimer's disease	0.000905	0.00156	CcSEcCtD
Naratriptan—Cough—Galantamine—Alzheimer's disease	0.000899	0.00155	CcSEcCtD
Naratriptan—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000895	0.00155	CcSEcCtD
Naratriptan—Convulsion—Galantamine—Alzheimer's disease	0.000893	0.00154	CcSEcCtD
Naratriptan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00089	0.00154	CcSEcCtD
Naratriptan—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00089	0.00154	CcSEcCtD
Naratriptan—Arthralgia—Galantamine—Alzheimer's disease	0.000877	0.00152	CcSEcCtD
Naratriptan—Myalgia—Galantamine—Alzheimer's disease	0.000877	0.00152	CcSEcCtD
Naratriptan—Anxiety—Galantamine—Alzheimer's disease	0.000874	0.00151	CcSEcCtD
Naratriptan—Sinusitis—Memantine—Alzheimer's disease	0.00087	0.0015	CcSEcCtD
Naratriptan—Sweating—Rivastigmine—Alzheimer's disease	0.00087	0.0015	CcSEcCtD
Naratriptan—Discomfort—Galantamine—Alzheimer's disease	0.000867	0.0015	CcSEcCtD
Naratriptan—Dry mouth—Galantamine—Alzheimer's disease	0.000858	0.00148	CcSEcCtD
Naratriptan—Tinnitus—Donepezil—Alzheimer's disease	0.000855	0.00148	CcSEcCtD
Naratriptan—Sinusitis—Rivastigmine—Alzheimer's disease	0.000851	0.00147	CcSEcCtD
Naratriptan—Confusional state—Galantamine—Alzheimer's disease	0.000848	0.00147	CcSEcCtD
Naratriptan—Bradycardia—Memantine—Alzheimer's disease	0.000848	0.00147	CcSEcCtD
Naratriptan—Haemoglobin—Memantine—Alzheimer's disease	0.000837	0.00145	CcSEcCtD
Naratriptan—Haemorrhage—Memantine—Alzheimer's disease	0.000833	0.00144	CcSEcCtD
Naratriptan—Bradycardia—Rivastigmine—Alzheimer's disease	0.000829	0.00143	CcSEcCtD
Naratriptan—Hypoaesthesia—Memantine—Alzheimer's disease	0.000829	0.00143	CcSEcCtD
Naratriptan—Hallucination—Memantine—Alzheimer's disease	0.000829	0.00143	CcSEcCtD
Naratriptan—Shock—Galantamine—Alzheimer's disease	0.000827	0.00143	CcSEcCtD
Naratriptan—Nervous system disorder—Galantamine—Alzheimer's disease	0.000825	0.00143	CcSEcCtD
Naratriptan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000823	0.00142	CcSEcCtD
Naratriptan—Chills—Donepezil—Alzheimer's disease	0.000823	0.00142	CcSEcCtD
Naratriptan—Arrhythmia—Donepezil—Alzheimer's disease	0.000819	0.00142	CcSEcCtD
Naratriptan—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000819	0.00142	CcSEcCtD
Naratriptan—Skin disorder—Galantamine—Alzheimer's disease	0.000817	0.00141	CcSEcCtD
Naratriptan—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000815	0.00141	CcSEcCtD
Naratriptan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000813	0.00141	CcSEcCtD
Naratriptan—Hallucination—Rivastigmine—Alzheimer's disease	0.000811	0.0014	CcSEcCtD
Naratriptan—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000811	0.0014	CcSEcCtD
Naratriptan—Alopecia—Donepezil—Alzheimer's disease	0.00081	0.0014	CcSEcCtD
Naratriptan—Erythema—Donepezil—Alzheimer's disease	0.000798	0.00138	CcSEcCtD
Naratriptan—Hypotension—Galantamine—Alzheimer's disease	0.000786	0.00136	CcSEcCtD
Naratriptan—Tinnitus—Memantine—Alzheimer's disease	0.000776	0.00134	CcSEcCtD
Naratriptan—Cardiac disorder—Memantine—Alzheimer's disease	0.000773	0.00134	CcSEcCtD
Naratriptan—Muscle spasms—Donepezil—Alzheimer's disease	0.000768	0.00133	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000766	0.00132	CcSEcCtD
Naratriptan—Tinnitus—Rivastigmine—Alzheimer's disease	0.00076	0.00131	CcSEcCtD
Naratriptan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000756	0.00131	CcSEcCtD
Naratriptan—Angiopathy—Memantine—Alzheimer's disease	0.000756	0.00131	CcSEcCtD
Naratriptan—Paraesthesia—Galantamine—Alzheimer's disease	0.000755	0.00131	CcSEcCtD
Naratriptan—Vision blurred—Donepezil—Alzheimer's disease	0.000752	0.0013	CcSEcCtD
Naratriptan—Immune system disorder—Memantine—Alzheimer's disease	0.000752	0.0013	CcSEcCtD
Naratriptan—Tremor—Donepezil—Alzheimer's disease	0.000748	0.00129	CcSEcCtD
Naratriptan—Somnolence—Galantamine—Alzheimer's disease	0.000747	0.00129	CcSEcCtD
Naratriptan—Chills—Memantine—Alzheimer's disease	0.000747	0.00129	CcSEcCtD
Naratriptan—Arrhythmia—Memantine—Alzheimer's disease	0.000744	0.00129	CcSEcCtD
Naratriptan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000741	0.00128	CcSEcCtD
Naratriptan—Angiopathy—Rivastigmine—Alzheimer's disease	0.000739	0.00128	CcSEcCtD
Naratriptan—Anaemia—Donepezil—Alzheimer's disease	0.000738	0.00128	CcSEcCtD
Naratriptan—Alopecia—Memantine—Alzheimer's disease	0.000736	0.00127	CcSEcCtD
Naratriptan—Agitation—Donepezil—Alzheimer's disease	0.000734	0.00127	CcSEcCtD
Naratriptan—Chills—Rivastigmine—Alzheimer's disease	0.000731	0.00126	CcSEcCtD
Naratriptan—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000728	0.00126	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000726	0.00125	CcSEcCtD
Naratriptan—Fatigue—Galantamine—Alzheimer's disease	0.000725	0.00125	CcSEcCtD
Naratriptan—Malaise—Donepezil—Alzheimer's disease	0.00072	0.00124	CcSEcCtD
Naratriptan—Alopecia—Rivastigmine—Alzheimer's disease	0.00072	0.00124	CcSEcCtD
Naratriptan—Constipation—Galantamine—Alzheimer's disease	0.000719	0.00124	CcSEcCtD
Naratriptan—Vertigo—Donepezil—Alzheimer's disease	0.000717	0.00124	CcSEcCtD
Naratriptan—Syncope—Donepezil—Alzheimer's disease	0.000716	0.00124	CcSEcCtD
Naratriptan—Erythema—Rivastigmine—Alzheimer's disease	0.000709	0.00123	CcSEcCtD
Naratriptan—Loss of consciousness—Donepezil—Alzheimer's disease	0.000702	0.00121	CcSEcCtD
Naratriptan—Cough—Donepezil—Alzheimer's disease	0.000697	0.0012	CcSEcCtD
Naratriptan—Feeling abnormal—Galantamine—Alzheimer's disease	0.000693	0.0012	CcSEcCtD
Naratriptan—Convulsion—Donepezil—Alzheimer's disease	0.000692	0.0012	CcSEcCtD
Naratriptan—Vision blurred—Memantine—Alzheimer's disease	0.000683	0.00118	CcSEcCtD
Naratriptan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000682	0.00118	CcSEcCtD
Naratriptan—Arthralgia—Donepezil—Alzheimer's disease	0.00068	0.00118	CcSEcCtD
Naratriptan—Myalgia—Donepezil—Alzheimer's disease	0.00068	0.00118	CcSEcCtD
Naratriptan—Tremor—Memantine—Alzheimer's disease	0.000679	0.00117	CcSEcCtD
Naratriptan—Anxiety—Donepezil—Alzheimer's disease	0.000677	0.00117	CcSEcCtD
Naratriptan—Ill-defined disorder—Memantine—Alzheimer's disease	0.000673	0.00116	CcSEcCtD
Naratriptan—Discomfort—Donepezil—Alzheimer's disease	0.000672	0.00116	CcSEcCtD
Naratriptan—Anaemia—Memantine—Alzheimer's disease	0.00067	0.00116	CcSEcCtD
Naratriptan—Vision blurred—Rivastigmine—Alzheimer's disease	0.000668	0.00116	CcSEcCtD
Naratriptan—Agitation—Memantine—Alzheimer's disease	0.000666	0.00115	CcSEcCtD
Naratriptan—Dry mouth—Donepezil—Alzheimer's disease	0.000665	0.00115	CcSEcCtD
Naratriptan—Body temperature increased—Galantamine—Alzheimer's disease	0.000665	0.00115	CcSEcCtD
Naratriptan—Tremor—Rivastigmine—Alzheimer's disease	0.000664	0.00115	CcSEcCtD
Naratriptan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000658	0.00114	CcSEcCtD
Naratriptan—Confusional state—Donepezil—Alzheimer's disease	0.000657	0.00114	CcSEcCtD
Naratriptan—Anaemia—Rivastigmine—Alzheimer's disease	0.000655	0.00113	CcSEcCtD
Naratriptan—Malaise—Memantine—Alzheimer's disease	0.000654	0.00113	CcSEcCtD
Naratriptan—Agitation—Rivastigmine—Alzheimer's disease	0.000652	0.00113	CcSEcCtD
Naratriptan—Oedema—Donepezil—Alzheimer's disease	0.000652	0.00113	CcSEcCtD
Naratriptan—Vertigo—Memantine—Alzheimer's disease	0.000651	0.00113	CcSEcCtD
Naratriptan—Syncope—Memantine—Alzheimer's disease	0.00065	0.00112	CcSEcCtD
Naratriptan—Infection—Donepezil—Alzheimer's disease	0.000647	0.00112	CcSEcCtD
Naratriptan—Shock—Donepezil—Alzheimer's disease	0.000641	0.00111	CcSEcCtD
Naratriptan—Palpitations—Memantine—Alzheimer's disease	0.000641	0.00111	CcSEcCtD
Naratriptan—Malaise—Rivastigmine—Alzheimer's disease	0.00064	0.00111	CcSEcCtD
Naratriptan—Nervous system disorder—Donepezil—Alzheimer's disease	0.000639	0.0011	CcSEcCtD
Naratriptan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000638	0.0011	CcSEcCtD
Naratriptan—Vertigo—Rivastigmine—Alzheimer's disease	0.000637	0.0011	CcSEcCtD
Naratriptan—Loss of consciousness—Memantine—Alzheimer's disease	0.000637	0.0011	CcSEcCtD
Naratriptan—Syncope—Rivastigmine—Alzheimer's disease	0.000636	0.0011	CcSEcCtD
Naratriptan—Cough—Memantine—Alzheimer's disease	0.000633	0.00109	CcSEcCtD
Naratriptan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00063	0.00109	CcSEcCtD
Naratriptan—Convulsion—Memantine—Alzheimer's disease	0.000628	0.00109	CcSEcCtD
Naratriptan—Palpitations—Rivastigmine—Alzheimer's disease	0.000627	0.00108	CcSEcCtD
Naratriptan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000623	0.00108	CcSEcCtD
Naratriptan—Hypersensitivity—Galantamine—Alzheimer's disease	0.000619	0.00107	CcSEcCtD
Naratriptan—Cough—Rivastigmine—Alzheimer's disease	0.000619	0.00107	CcSEcCtD
Naratriptan—Myalgia—Memantine—Alzheimer's disease	0.000617	0.00107	CcSEcCtD
Naratriptan—Arthralgia—Memantine—Alzheimer's disease	0.000617	0.00107	CcSEcCtD
Naratriptan—Anxiety—Memantine—Alzheimer's disease	0.000615	0.00106	CcSEcCtD
Naratriptan—Convulsion—Rivastigmine—Alzheimer's disease	0.000614	0.00106	CcSEcCtD
Naratriptan—Discomfort—Memantine—Alzheimer's disease	0.00061	0.00105	CcSEcCtD
Naratriptan—Hypotension—Donepezil—Alzheimer's disease	0.000609	0.00105	CcSEcCtD
Naratriptan—Arthralgia—Rivastigmine—Alzheimer's disease	0.000604	0.00104	CcSEcCtD
Naratriptan—Myalgia—Rivastigmine—Alzheimer's disease	0.000604	0.00104	CcSEcCtD
Naratriptan—Dry mouth—Memantine—Alzheimer's disease	0.000604	0.00104	CcSEcCtD
Naratriptan—Asthenia—Galantamine—Alzheimer's disease	0.000603	0.00104	CcSEcCtD
Naratriptan—Anxiety—Rivastigmine—Alzheimer's disease	0.000602	0.00104	CcSEcCtD
Naratriptan—Confusional state—Memantine—Alzheimer's disease	0.000597	0.00103	CcSEcCtD
Naratriptan—Discomfort—Rivastigmine—Alzheimer's disease	0.000597	0.00103	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000594	0.00103	CcSEcCtD
Naratriptan—Oedema—Memantine—Alzheimer's disease	0.000592	0.00102	CcSEcCtD
Naratriptan—Dry mouth—Rivastigmine—Alzheimer's disease	0.00059	0.00102	CcSEcCtD
Naratriptan—Infection—Memantine—Alzheimer's disease	0.000588	0.00102	CcSEcCtD
Naratriptan—Paraesthesia—Donepezil—Alzheimer's disease	0.000585	0.00101	CcSEcCtD
Naratriptan—Confusional state—Rivastigmine—Alzheimer's disease	0.000584	0.00101	CcSEcCtD
Naratriptan—Shock—Memantine—Alzheimer's disease	0.000582	0.00101	CcSEcCtD
Naratriptan—Dyspnoea—Donepezil—Alzheimer's disease	0.000581	0.001	CcSEcCtD
Naratriptan—Nervous system disorder—Memantine—Alzheimer's disease	0.00058	0.001	CcSEcCtD
Naratriptan—Somnolence—Donepezil—Alzheimer's disease	0.000579	0.001	CcSEcCtD
Naratriptan—Thrombocytopenia—Memantine—Alzheimer's disease	0.000579	0.001	CcSEcCtD
Naratriptan—Oedema—Rivastigmine—Alzheimer's disease	0.000579	0.001	CcSEcCtD
Naratriptan—Diarrhoea—Galantamine—Alzheimer's disease	0.000575	0.000995	CcSEcCtD
Naratriptan—Infection—Rivastigmine—Alzheimer's disease	0.000575	0.000994	CcSEcCtD
Naratriptan—Skin disorder—Memantine—Alzheimer's disease	0.000575	0.000994	CcSEcCtD
Naratriptan—Hyperhidrosis—Memantine—Alzheimer's disease	0.000572	0.000989	CcSEcCtD
Naratriptan—Shock—Rivastigmine—Alzheimer's disease	0.000569	0.000984	CcSEcCtD
Naratriptan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000568	0.000981	CcSEcCtD
Naratriptan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000567	0.00098	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000563	0.000973	CcSEcCtD
Naratriptan—Skin disorder—Rivastigmine—Alzheimer's disease	0.000562	0.000972	CcSEcCtD
Naratriptan—Fatigue—Donepezil—Alzheimer's disease	0.000562	0.000971	CcSEcCtD
Naratriptan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00056	0.000967	CcSEcCtD
Naratriptan—Pain—Donepezil—Alzheimer's disease	0.000557	0.000963	CcSEcCtD
Naratriptan—Constipation—Donepezil—Alzheimer's disease	0.000557	0.000963	CcSEcCtD
Naratriptan—Dizziness—Galantamine—Alzheimer's disease	0.000556	0.000961	CcSEcCtD
Naratriptan—Hypotension—Memantine—Alzheimer's disease	0.000553	0.000956	CcSEcCtD
Naratriptan—Hypotension—Rivastigmine—Alzheimer's disease	0.000541	0.000935	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000539	0.000932	CcSEcCtD
Naratriptan—Feeling abnormal—Donepezil—Alzheimer's disease	0.000537	0.000928	CcSEcCtD
Naratriptan—Vomiting—Galantamine—Alzheimer's disease	0.000535	0.000924	CcSEcCtD
Naratriptan—Paraesthesia—Memantine—Alzheimer's disease	0.000531	0.000918	CcSEcCtD
Naratriptan—Rash—Galantamine—Alzheimer's disease	0.00053	0.000917	CcSEcCtD
Naratriptan—Dermatitis—Galantamine—Alzheimer's disease	0.00053	0.000916	CcSEcCtD
Naratriptan—Dyspnoea—Memantine—Alzheimer's disease	0.000527	0.000912	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000527	0.000912	CcSEcCtD
Naratriptan—Headache—Galantamine—Alzheimer's disease	0.000527	0.000911	CcSEcCtD
Naratriptan—Somnolence—Memantine—Alzheimer's disease	0.000526	0.000909	CcSEcCtD
Naratriptan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00052	0.000899	CcSEcCtD
Naratriptan—Urticaria—Donepezil—Alzheimer's disease	0.000518	0.000895	CcSEcCtD
Naratriptan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000516	0.000892	CcSEcCtD
Naratriptan—Body temperature increased—Donepezil—Alzheimer's disease	0.000515	0.000891	CcSEcCtD
Naratriptan—Somnolence—Rivastigmine—Alzheimer's disease	0.000515	0.00089	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000511	0.000883	CcSEcCtD
Naratriptan—Fatigue—Memantine—Alzheimer's disease	0.00051	0.000882	CcSEcCtD
Naratriptan—Pain—Memantine—Alzheimer's disease	0.000506	0.000875	CcSEcCtD
Naratriptan—Constipation—Memantine—Alzheimer's disease	0.000506	0.000875	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.0005	0.000864	CcSEcCtD
Naratriptan—Nausea—Galantamine—Alzheimer's disease	0.000499	0.000863	CcSEcCtD
Naratriptan—Fatigue—Rivastigmine—Alzheimer's disease	0.000499	0.000863	CcSEcCtD
Naratriptan—Pain—Rivastigmine—Alzheimer's disease	0.000495	0.000856	CcSEcCtD
Naratriptan—Constipation—Rivastigmine—Alzheimer's disease	0.000495	0.000856	CcSEcCtD
Naratriptan—Feeling abnormal—Memantine—Alzheimer's disease	0.000488	0.000843	CcSEcCtD
Naratriptan—Hypersensitivity—Donepezil—Alzheimer's disease	0.00048	0.00083	CcSEcCtD
Naratriptan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000477	0.000825	CcSEcCtD
Naratriptan—Urticaria—Memantine—Alzheimer's disease	0.00047	0.000813	CcSEcCtD
Naratriptan—Body temperature increased—Memantine—Alzheimer's disease	0.000468	0.000809	CcSEcCtD
Naratriptan—Asthenia—Donepezil—Alzheimer's disease	0.000468	0.000808	CcSEcCtD
Naratriptan—Pruritus—Donepezil—Alzheimer's disease	0.000461	0.000797	CcSEcCtD
Naratriptan—Urticaria—Rivastigmine—Alzheimer's disease	0.00046	0.000795	CcSEcCtD
Naratriptan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000458	0.000791	CcSEcCtD
Naratriptan—Diarrhoea—Donepezil—Alzheimer's disease	0.000446	0.000771	CcSEcCtD
Naratriptan—Hypersensitivity—Memantine—Alzheimer's disease	0.000436	0.000754	CcSEcCtD
Naratriptan—Dizziness—Donepezil—Alzheimer's disease	0.000431	0.000745	CcSEcCtD
Naratriptan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000426	0.000737	CcSEcCtD
Naratriptan—Asthenia—Memantine—Alzheimer's disease	0.000424	0.000734	CcSEcCtD
Naratriptan—Pruritus—Memantine—Alzheimer's disease	0.000419	0.000724	CcSEcCtD
Naratriptan—Asthenia—Rivastigmine—Alzheimer's disease	0.000415	0.000718	CcSEcCtD
Naratriptan—Vomiting—Donepezil—Alzheimer's disease	0.000414	0.000716	CcSEcCtD
Naratriptan—Rash—Donepezil—Alzheimer's disease	0.000411	0.00071	CcSEcCtD
Naratriptan—Dermatitis—Donepezil—Alzheimer's disease	0.00041	0.00071	CcSEcCtD
Naratriptan—Pruritus—Rivastigmine—Alzheimer's disease	0.000409	0.000708	CcSEcCtD
Naratriptan—Headache—Donepezil—Alzheimer's disease	0.000408	0.000706	CcSEcCtD
Naratriptan—Diarrhoea—Memantine—Alzheimer's disease	0.000405	0.0007	CcSEcCtD
Naratriptan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000396	0.000685	CcSEcCtD
Naratriptan—Dizziness—Memantine—Alzheimer's disease	0.000391	0.000676	CcSEcCtD
Naratriptan—Nausea—Donepezil—Alzheimer's disease	0.000387	0.000669	CcSEcCtD
Naratriptan—Dizziness—Rivastigmine—Alzheimer's disease	0.000383	0.000662	CcSEcCtD
Naratriptan—Vomiting—Memantine—Alzheimer's disease	0.000376	0.00065	CcSEcCtD
Naratriptan—Rash—Memantine—Alzheimer's disease	0.000373	0.000645	CcSEcCtD
Naratriptan—Dermatitis—Memantine—Alzheimer's disease	0.000373	0.000644	CcSEcCtD
Naratriptan—Headache—Memantine—Alzheimer's disease	0.000371	0.000641	CcSEcCtD
Naratriptan—Vomiting—Rivastigmine—Alzheimer's disease	0.000368	0.000636	CcSEcCtD
Naratriptan—Rash—Rivastigmine—Alzheimer's disease	0.000365	0.000631	CcSEcCtD
Naratriptan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000365	0.00063	CcSEcCtD
Naratriptan—Headache—Rivastigmine—Alzheimer's disease	0.000363	0.000627	CcSEcCtD
Naratriptan—Nausea—Memantine—Alzheimer's disease	0.000351	0.000608	CcSEcCtD
Naratriptan—Nausea—Rivastigmine—Alzheimer's disease	0.000344	0.000594	CcSEcCtD
Naratriptan—MAOA—Metabolism—A2M—Alzheimer's disease	7.81e-05	0.00033	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGFR—Alzheimer's disease	7.77e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CREB1—Alzheimer's disease	7.72e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NPS—Alzheimer's disease	7.66e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	7.63e-05	0.000323	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR6—Alzheimer's disease	7.59e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADAM10—Alzheimer's disease	7.59e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL2—Alzheimer's disease	7.55e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—A2M—Alzheimer's disease	7.44e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	7.4e-05	0.000313	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.34e-05	0.00031	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—SST—Alzheimer's disease	7.31e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GAB2—Alzheimer's disease	7.31e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—A2M—Alzheimer's disease	7.29e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PSEN2—Alzheimer's disease	7.21e-05	0.000305	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.19e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—S100B—Alzheimer's disease	7.17e-05	0.000303	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	7.15e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—APP—Alzheimer's disease	7.12e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PSEN2—Alzheimer's disease	7.06e-05	0.000299	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL2—Alzheimer's disease	7.02e-05	0.000297	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR5—Alzheimer's disease	6.95e-05	0.000294	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PSENEN—Alzheimer's disease	6.89e-05	0.000291	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF2—Alzheimer's disease	6.83e-05	0.000289	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCR5—Alzheimer's disease	6.81e-05	0.000288	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.81e-05	0.000288	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ACHE—Alzheimer's disease	6.8e-05	0.000287	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APH1A—Alzheimer's disease	6.79e-05	0.000287	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	6.72e-05	0.000284	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INPP5D—Alzheimer's disease	6.72e-05	0.000284	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PRKCG—Alzheimer's disease	6.66e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.66e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NPY—Alzheimer's disease	6.64e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	6.61e-05	0.00028	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1R—Alzheimer's disease	6.6e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IAPP—Alzheimer's disease	6.59e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PRKCG—Alzheimer's disease	6.53e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NPY—Alzheimer's disease	6.5e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IAPP—Alzheimer's disease	6.46e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	6.45e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CRH—Alzheimer's disease	6.4e-05	0.000271	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS1—Alzheimer's disease	6.37e-05	0.000269	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ENO1—Alzheimer's disease	6.37e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LPL—Alzheimer's disease	6.33e-05	0.000268	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR5—Alzheimer's disease	6.32e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	6.3e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	6.3e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MEF2C—Alzheimer's disease	6.28e-05	0.000265	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CRH—Alzheimer's disease	6.27e-05	0.000265	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP2D6—Alzheimer's disease	6.25e-05	0.000264	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR5—Alzheimer's disease	6.18e-05	0.000262	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—Alzheimer's disease	6.18e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRKCG—Alzheimer's disease	6.16e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NPS—Alzheimer's disease	6.07e-05	0.000257	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.05e-05	0.000256	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PPP3CA—Alzheimer's disease	6.04e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGF—Alzheimer's disease	6e-05	0.000254	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—F2—Alzheimer's disease	5.97e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTK2B—Alzheimer's disease	5.95e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NPS—Alzheimer's disease	5.94e-05	0.000251	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—BCHE—Alzheimer's disease	5.92e-05	0.00025	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PPP3CA—Alzheimer's disease	5.91e-05	0.00025	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—F2—Alzheimer's disease	5.84e-05	0.000247	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR5—Alzheimer's disease	5.83e-05	0.000247	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTK2B—Alzheimer's disease	5.83e-05	0.000246	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GAB2—Alzheimer's disease	5.79e-05	0.000245	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK2—Alzheimer's disease	5.79e-05	0.000245	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SST—Alzheimer's disease	5.79e-05	0.000245	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CALM1—Alzheimer's disease	5.77e-05	0.000244	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GSK3A—Alzheimer's disease	5.74e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—Alzheimer's disease	5.71e-05	0.000241	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK2—Alzheimer's disease	5.67e-05	0.00024	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SST—Alzheimer's disease	5.67e-05	0.00024	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GAB2—Alzheimer's disease	5.67e-05	0.00024	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CALM1—Alzheimer's disease	5.65e-05	0.000239	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APP—Alzheimer's disease	5.64e-05	0.000239	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GSK3A—Alzheimer's disease	5.62e-05	0.000238	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PLCB1—Alzheimer's disease	5.59e-05	0.000236	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	5.55e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APP—Alzheimer's disease	5.52e-05	0.000234	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	5.47e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—F2—Alzheimer's disease	5.42e-05	0.000229	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCA1—Alzheimer's disease	5.42e-05	0.000229	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	5.38e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CALM1—Alzheimer's disease	5.33e-05	0.000225	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PLCB1—Alzheimer's disease	5.32e-05	0.000225	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—Alzheimer's disease	5.31e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LEP—Alzheimer's disease	5.31e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—F2—Alzheimer's disease	5.31e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CAV1—Alzheimer's disease	5.26e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PLCB1—Alzheimer's disease	5.21e-05	0.00022	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	5.19e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.08e-05	0.000215	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ESR1—Alzheimer's disease	5.07e-05	0.000214	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—F2—Alzheimer's disease	5.01e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	4.97e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGFR—Alzheimer's disease	4.97e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	4.95e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CREB1—Alzheimer's disease	4.94e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	4.92e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOTCH1—Alzheimer's disease	4.9e-05	0.000207	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGFR—Alzheimer's disease	4.86e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADAM10—Alzheimer's disease	4.85e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CREB1—Alzheimer's disease	4.83e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL2—Alzheimer's disease	4.83e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	4.78e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADAM10—Alzheimer's disease	4.75e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL2—Alzheimer's disease	4.73e-05	0.0002	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	4.71e-05	0.000199	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	4.67e-05	0.000197	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HMOX1—Alzheimer's disease	4.65e-05	0.000197	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	4.61e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GSK3B—Alzheimer's disease	4.6e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—S100B—Alzheimer's disease	4.59e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CREB1—Alzheimer's disease	4.56e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—Alzheimer's disease	4.53e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	4.53e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	4.5e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—S100B—Alzheimer's disease	4.49e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL2—Alzheimer's disease	4.46e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	4.45e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	4.44e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—Alzheimer's disease	4.39e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—Alzheimer's disease	4.37e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	4.32e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	4.32e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SST—Alzheimer's disease	4.32e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	4.3e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	4.28e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—Alzheimer's disease	4.28e-05	0.000181	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—LPL—Alzheimer's disease	4.25e-05	0.00018	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1R—Alzheimer's disease	4.22e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APP—Alzheimer's disease	4.21e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1R—Alzheimer's disease	4.14e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LPL—Alzheimer's disease	4.05e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	4.04e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MEF2C—Alzheimer's disease	4.01e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—Alzheimer's disease	3.98e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	3.97e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LPL—Alzheimer's disease	3.96e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCG—Alzheimer's disease	3.94e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MEF2C—Alzheimer's disease	3.93e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCG—Alzheimer's disease	3.86e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGF—Alzheimer's disease	3.84e-05	0.000162	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—Alzheimer's disease	3.83e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGF—Alzheimer's disease	3.76e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—Alzheimer's disease	3.73e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	3.71e-05	0.000157	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	3.68e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—Alzheimer's disease	3.65e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—Alzheimer's disease	3.65e-05	0.000154	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	3.62e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	3.6e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—Alzheimer's disease	3.57e-05	0.000151	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CALM1—Alzheimer's disease	3.57e-05	0.000151	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—Alzheimer's disease	3.56e-05	0.000151	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—Alzheimer's disease	3.53e-05	0.000149	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	3.42e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—Alzheimer's disease	3.41e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALM1—Alzheimer's disease	3.41e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—Alzheimer's disease	3.39e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—Alzheimer's disease	3.39e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—Alzheimer's disease	3.38e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—Alzheimer's disease	3.36e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—Alzheimer's disease	3.35e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALM1—Alzheimer's disease	3.34e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—Alzheimer's disease	3.32e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—Alzheimer's disease	3.32e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—Alzheimer's disease	3.29e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	3.26e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ESR1—Alzheimer's disease	3.24e-05	0.000137	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—F2—Alzheimer's disease	3.2e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ESR1—Alzheimer's disease	3.17e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	3.15e-05	0.000133	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—F2—Alzheimer's disease	3.13e-05	0.000133	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	3.13e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—Alzheimer's disease	3.1e-05	0.000131	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—Alzheimer's disease	3.1e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—Alzheimer's disease	3.09e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.07e-05	0.00013	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—Alzheimer's disease	3.04e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	3.02e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	2.99e-05	0.000127	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	2.94e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	2.94e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	2.92e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—Alzheimer's disease	2.9e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	2.88e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—Alzheimer's disease	2.86e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	2.86e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	2.86e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	2.85e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—Alzheimer's disease	2.84e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	2.8e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	2.79e-05	0.000118	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	2.78e-05	0.000118	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	2.75e-05	0.000116	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	2.72e-05	0.000115	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—Alzheimer's disease	2.67e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—Alzheimer's disease	2.63e-05	0.000111	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	2.54e-05	0.000108	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	2.54e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	2.53e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	2.53e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	2.51e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	2.49e-05	0.000105	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—Alzheimer's disease	2.44e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	2.42e-05	0.000102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—F2—Alzheimer's disease	2.39e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.34e-05	9.88e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.19e-05	9.27e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-05	9.22e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.17e-05	9.2e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—Alzheimer's disease	2.16e-05	9.16e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—Alzheimer's disease	2.16e-05	9.15e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-05	9.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	2.14e-05	9.07e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.13e-05	9.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.13e-05	9e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	2.11e-05	8.94e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	2.1e-05	8.88e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.09e-05	8.85e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.98e-05	8.39e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—Alzheimer's disease	1.98e-05	8.38e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-05	8.37e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.94e-05	8.22e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.94e-05	8.19e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.9e-05	8.02e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.83e-05	7.75e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—Alzheimer's disease	1.83e-05	7.73e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.79e-05	7.59e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-05	7.11e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.65e-05	6.96e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.63e-05	6.87e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.61e-05	6.81e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.6e-05	6.77e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.48e-05	6.26e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.48e-05	6.24e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.38e-05	5.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-05	5.78e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.36e-05	5.73e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.27e-05	5.36e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.25e-05	5.3e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.24e-05	5.25e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—Alzheimer's disease	1.23e-05	5.19e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-05	4.94e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.14e-05	4.84e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.03e-05	4.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.45e-06	4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	8.72e-06	3.69e-05	CbGpPWpGaD
